Vera Therapeutics, Inc. (VERA) Net income 2020–2025
Vera Therapeutics, Inc. (VERA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$299.6MFY2025 · since FY2020: -$53.4M → -$299.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$299.6M | -96.9% |
| FY2024 | -$152.1M | -58.5% |
| FY2023 | -$96.0M | -7.8% |
| FY2022 | -$89.1M | -173.1% |
| FY2021 | -$32.6M | +38.9% |
| FY2020 | -$53.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VERA financial trends
VERA RevenueVERA Net marginVERA Gross profitVERA Gross marginVERA Operating incomeVERA Operating marginVERA Operating cash flowVERA Free cash flowVERA Capital expendituresVERA Return on equityVERA Stock buybacksVERA Dividends paidVERA Total assetsVERA Total liabilitiesVERA Shareholders’ equityVERA overview →